REFERENCES

  1. National Biodefense Strategy and Implementation Plan for Countering Biological Threats, Enhancing Pandemic Preparedness, and Achieving Global Health Security. https://www.whitehouse.gov/wp content/uploads/2022/10/National-Biodefense-Strategy-and-Implementation-Plan-Final.pdf
  2. DoD Biodefense Posture Review. https://media.defense.gov/2023/Aug/17/2003282337/-1/-1/1/2023_BIODEFENSE_POSTURE_REVIEW.PDF
  3. Army Biological Defense Strategy. https://armypubs.army.mil/epubs/DR_pubs/DR_a/ARN32553-SD_04_STRATEGY_NOTE_2021-01-000-WEB-1.pdf
  4. DoD Instruction 1322.24, Medical Readiness Training, 15 Feb 2022 as amended
  5. North Atlantic Treaty Organization (NATO). Medical Management of CBRN Casualties. NATO Standard AMedP-7.1. Edition A Version 1. Brussels, Belgium: NATO Standardization Office (NSO), June 2018. https://www.coemed.org/files/stanags/03_AMEDP/AMedP-7.1_EDA_V1_E_2461.pdf
  6. NATO Term, the Official NATO Terminology Database. https://nso.nato.int/natoterm/Web.mvc
  7. North Atlantic Treaty Organization. Allied Joint Chemical, Biological, Radiological and Nuclear (CBRN) Medical Support Doctrine. NATO Standard AMedP-7. Edition B Version 1. Brussels, Belgium: NATO Standardization Office, Jan 2022.
  8. CDC. What are “emerging” infectious diseases? https://wwwnc.cdc.gov/eid/about/background#:~:text=Infectious%20diseases%20whose%20incidence%20in,or%20evolution%20of%20existing%20organisms
  9. Chua KB. Nipah virus outbreak in Malaysia. J Clin Virol. 2003 Apr;26(3):265-75.
  10. National Library of Medicine. MedGen. Endemic Disease. https://www.ncbi.nlm.nih.gov/medgen/?term=endemic+disease
  11. High Consequence Infectious Diseases. https://www.gov.uk/guidance/high-consequence-infectious-diseases-hcid
  12. JP 4-02. Joint Health Services. 29 Aug 2023.
  13. The Joint Commission. New and Revised Requirements for Infection Prevention and Control for Critical Access Hospitals and Hospitals. https://www.jointcommission.org/-/media/tjc/documents/standards/r3-reports/r3_report_ic_rewrite-hap_cah.pdf  
  14. Department of Transportation. Transporting Infectious Substances. https://www.phmsa.dot.gov/transporting-infectious-substances/transporting-infectious-substances-overview  
  15. National Library of Medicine. MedGen. Communicable Diseases, Imported. https://www.ncbi.nlm.nih.gov/medgen/1387325#:~:text=Definition,animal%2C%20or%20disease%20vector.%20%5B
  16. JP 3-11. Operations in Chemical, Biological, Radiological, and Nuclear Environments. 28 Oct 2020 https://www.jcs.mil/Portals/36/Documents/Doctrine/pubs/jp3_11.pdf  
  17. CDC. Select Agents and Toxins List. https://www.selectagents.gov/sat/list.htm
  18. Murray CK, Horvath LL, Ericsson CD, Hatz C. An approach to prevention of infectious diseases during military deployments. Clinical Infectious Diseases. 2007 Feb 1;44(3):424-30.
  19. Smallman-Raynor MR, Cliff AD. Impact of infectious diseases on war. Infectious Disease Clinics. 2004 Jun 1;18(2):341-68.
  20. Murray CK, Yun HC, Markelz AE, Okulicz JF, Vento TJ, Burgess TH, Cardile AP, Miller RS. Operation United Assistance: infectious disease threats to deployed military personnel. Mil Med. 2015 Jun 1;180(6):626-51.
  21. Lalani T, Fraser J, Riddle MS, Gutierrez RL, Hickey PW, Tribble DR. Deployment Infectious Disease Threats: IDCRP Initiatives and Vision Forward. Mil Med. 2019 Nov 1;184(Suppl 2):26-34.
  22. CDC. Bioterrorism Agents/Diseases. https://emergency.cdc.gov/agent/agentlist-category.asp#catdef
  23. Zilinskas, Raymond A., ed. Biological warfare: modern offense and defense. Lynne Rienner Publishers, 2000.
  24. Katz, Rebecca, and Raymond A. Zilinskas. Encyclopedia of bioterrorism defense. No. Ed. 2. Wiley-Blackwell, 2011.
  25. Multi-service tactics, techniques, and procedures for treatment of biological warfare agent casualties (MCRP 3-40A.3, NTRP 4-02.23, AFMAN 44-156_IP). https://armypubs.army.mil/epubs/DR_pubs/DR_a/pdf/web/ARN19960_ATP%204-02x84%20FINAL%20WEB.pdf
  26. ATP 4-02.7/MCRP 4-11.1F/NTTP 4-02.7/AFTTP 3-42.3. Multiservice Tactics, Techniques, and Procedures for Health Service Support in a Chemical, Biological, Radiological, and Nuclear Environment, dated March 2016.
  27. USAMRIID's medical management of biological casualties handbook. 9th edition. https://usamriid.health.mil/assets/docs/training/USAMRIIDs_Blue_Book_9th_edition_PDF_format.pdf#
  28. Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD). Dual Use Research of Concern and Bird Flu: Questions & Answers, 13 May 2019. https://www.cdc.gov/flu/avianflu/avian-durc-qa.htm  Accessed Mar 2023.
  29. JTS Global Snake Envenomation Management, 30 Jun 2020 CPG https://jts.health.mil/index.cfm/PI_CPGs/cpgs
  30. JTS Global Spider and Scorpion Envenomation, 09 Feb 2021 CPGhttps://jts.health.mil/index.cfm/PI_CPGs/cpgs
  31. CDC. CDC’s core infection prevention and control practices for safe healthcare delivery in all settings. https://www.cdc.gov/infectioncontrol/guidelines/core-practices/index.html
  32. ATP 4-02.10. Theater Hospitalization. August 2020. https://armypubs.army.mil/epubs/DR_pubs/DR_a/ARN30125-ATP_4-02.10-000-WEB-1.pdf
  33. WHO. Infection prevention and control guideline for Ebola and Marburg disease. August 2023. https://iris.who.int/bitstream/handle/10665/372261/WHO-WPE-CRS-HCR-2023.1-eng.pdf?sequence=1
  34. WHO. Clinical management of patients with viral haemorrhagic fever: A pocket guide for front-line health workers. https://iris.who.int/bitstream/handle/10665/205570/9789241549608_eng.pdf?sequence=1
  35. CDC. Infection prevention and control recommendations for patients in U.S. hospitals who are suspected or confirmed to have selected viral hemorrhagic fevers (VHF). https://www.cdc.gov/viral-hemorrhagic-fevers/hcp/infection-control/index.html Accessed July 21, 2024.
  36. Siegel JD, Rhinehart E, Jackson M, et al. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings https://www.cdc.gov/infection-control/hcp/isolation-precautions/?CDC_AAref_Val=https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html
  37. WHO. Clinical management of patients with viral haemorrhagic fever: A pocket guide for front-line health workers. https://iris.who.int/bitstream/handle/10665/205570/9789241549608_eng.pdf?sequence=1
  38. CDC. Fact Sheet about Andes Virus. https://www.cdc.gov/hantavirus/resources/andes-virus.html
  39. Alonso DO, Pérez-Sautu U, Bellomo CM, et al. Person-to-person transmission of Andes virus in Hantavirus Pulmonary Syndrome, Argentina, 2014. Emerg Infect Dis. 2020 Apr;26(4):756-759.
  40. Infection Prevention in Combat-related Injuries. https://jts.health.mil/assets/docs/cpgs/Infection_Prevention_in_Combat-related_Injuries_27_Jan_2021_ID24.pdf
  41. Mc Gann PT, Lebreton F, Jones BT, et al. Six extensively drug-resistant bacteria in an injured soldier, Ukraine. Emerg Infect Dis. 2023 Aug;29(8):1692-1695.
  42. Yun HC, Murray CK. Infection prevention in the deployed environment. US Army Med Dep J. 2016 Apr-Sep;(2-16):114-8.
  43. Hospenthal DR, Green AD, Crouch HK, et al. Prevention of Combat-Related Infections Guidelines Panel. Infection prevention and control in deployed military medical treatment facilities. J Trauma. 2011 Aug;71(2 Suppl 2):S290-8.
  44. Hospenthal DR, Crouch HK, English JF, et al. Response to infection control challenges in the deployed setting: Operations Iraqi and Enduring Freedom. J Trauma. 2010 Jul;69 Suppl 1:S94-101.
  45. Crouch HK, Murray CK, Hospenthal DR. Development of a deployment infection control course. Mil Med. 2010 Dec;175(12):983-9.
  46. Barsoumian AE, Solberg SL, Hanhurst AS, et al. Status update on infection prevention and control at deployed medical treatment facilities. Mil Med. 2020 Mar 2;185(3-4):451-460.
  47. ASPR TRACIE. EMS Infectious Disease Playbook. https://files.asprtracie.hhs.gov/documents/aspr-tracie-transport-playbook-508.pdf Accessed July 21, 2024.
  48. Field Management of Chemical and Biological Casualties Handbook. https://medcoe.army.mil/borden-field-mgt-of-cb-casualities
  49. JTS CPG. Chemical, biological, radiological and nuclear injury response part I: initial response. https://jts.health.mil/assets/docs/cpgs/Chemical_Biological,_Radiological_Nuclear_Injury_Part1_Initial_Response_01_May_2018_ID69.pdf
  50. JTS telemedicine in the deployed setting, 19 Sep 2023 CPG. https://jts.health.mil/index.cfm/PI_CPGs/cpgs
  51. Mulangu S, Dodd LE, Davey RT Jr, et al. PALM Consortium Study Team. A randomized, controlled trial of Ebola virus disease Therapeutics. N Engl J Med. 2019 Dec 12;381(24):2293-2303.
  52. Torti C, Olimpieri PP, Bonfanti P, et al. Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study. Lancet Reg Health Eur. 2023 Jul 14;31:100684.
  53. Moreno G, Rodríguez A, Sole-Violán J, et al. Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia. ERJ Open Res. 2021 Mar 8;7(1):00888-2020.
  54. Patel GP, Simon D, Scheetz M, Crank CW, Lodise T, Patel N. The effect of time to antifungal therapy on mortality in Candidemia associated septic shock. Am J Ther. 2009 Nov-Dec;16(6):508-11.
  55. Mousa A, Al-Taiar A, Anstey NM, et al. The impact of delayed treatment of uncomplicated P. falciparum malaria on progression to severe malaria: A systematic review and a pooled multicentre individual-patient meta-analysis. PLoS Med. 2020 Oct 19;17(10):e1003359.
  56. Surviving Sepsis Campaign. https://www.sccm.org/SurvivingSepsisCampaign/Home
  57. JTS Sepsis management in prolonged field care. 28 Oct 2020 CPG. https://jts.health.mil/index.cfm/PI_CPGs/cpgs
  58. Report of the Project Team for Smart Defence Project 1.1045: Volume 2 concept of operations for bio-response. https://www.ida.org/research-and-publications/publications/all/r/re/report-of-the-project-team-for-smart-defence-project-1-1045-volume-2-conops-for-bio-response
  59. The CDC Field Epidemiology Manual. https://www.cdc.gov/eis/field-epi-manual/index.html